Celltrion
068270.KS
#755
Rank
C$46.06 B
Marketcap
C$202.01
Share price
1.22%
Change (1 day)
17.00%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): C$4.56

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$4.55. In 2025 the company made an earnings per share (EPS) of C$4.32 an increase over its 2024 EPS that were of C$1.64.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.565.46%
2025C$4.32163.66%
2024C$1.64-53.73%
2023C$3.54-2.08%
2022C$3.62-11.72%
2021C$4.102.03%
2020C$4.0182.8%
2019C$2.2018.31%
2018C$1.86-36.33%
2017C$2.92161.25%
2016C$1.122.86%
2015C$1.0917.84%
2014C$0.925.87%
2013C$0.87-70.85%
2012C$2.98134.09%
2011C$1.2743.59%
2010C$0.8974.49%
2009C$0.51317.8%
2008C$0.12-71.7%
2007C$0.43